The Clinical Section (CS) is responsible for the design and implementation of clinical protocols with an emphasis on pharmacokinetic and/or pharmacogenomic-driven study objectives. The CS manages several CCR-wide biospecimen collection protocols to enable pharmacokinetic and pharmacogenomic analyses.
For closed clinical protocols, the CS facilitates and manages long-term retention of valuable clinical samples to preserve the possibility of future retrospective studies.
The CS also provides clinical protocol support for CCR investigators to ensure that appropriate considerations for biospecimen collection and study objectives that rely on pharmacology-based analyses are written into protocols prior to IRB review.
Lastly, the CS initiates, designs and oversees CCR clinical trials based on scientific rationales generated from ongoing translational research either from within the CPP or in collaboration with other CCR clinical investigators.
Questions? Contact Keith Schmidt, keith.schmidt@nih.gov